295 related articles for article (PubMed ID: 31315045)
1. Deficiency in BDNF/TrkB Neurotrophic Activity Stimulates δ-Secretase by Upregulating C/EBPβ in Alzheimer's Disease.
Wang ZH; Xiang J; Liu X; Yu SP; Manfredsson FP; Sandoval IM; Wu S; Wang JZ; Ye K
Cell Rep; 2019 Jul; 28(3):655-669.e5. PubMed ID: 31315045
[TBL] [Abstract][Full Text] [Related]
2. Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer's disease pathologies.
Xiang J; Wang ZH; Ahn EH; Liu X; Yu SP; Manfredsson FP; Sandoval IM; Ju G; Wu S; Ye K
Proc Natl Acad Sci U S A; 2019 Apr; 116(18):9094-9102. PubMed ID: 31004063
[TBL] [Abstract][Full Text] [Related]
3. FSH and ApoE4 contribute to Alzheimer's disease-like pathogenesis via C/EBPβ/δ-secretase in female mice.
Xiong J; Kang SS; Wang M; Wang Z; Xia Y; Liao J; Liu X; Yu SP; Zhang Z; Ryu V; Yuen T; Zaidi M; Ye K
Nat Commun; 2023 Oct; 14(1):6577. PubMed ID: 37852961
[TBL] [Abstract][Full Text] [Related]
4. Intranasal insulin intake and exercise improve memory function in amyloid-β induced Alzheimer's-like disease in rats: Involvement of hippocampal BDNF-TrkB receptor.
Farokhi Larijani S; Hassanzadeh G; Zahmatkesh M; Radfar F; Farahmandfar M
Behav Brain Res; 2024 Mar; 460():114814. PubMed ID: 38104636
[TBL] [Abstract][Full Text] [Related]
5. Neurotrophin/Trk receptor signaling mediates C/EBPalpha, -beta and NeuroD recruitment to immediate-early gene promoters in neuronal cells and requires C/EBPs to induce immediate-early gene transcription.
Calella AM; Nerlov C; Lopez RG; Sciarretta C; von Bohlen und Halbach O; Bereshchenko O; Minichiello L
Neural Dev; 2007 Jan; 2():4. PubMed ID: 17254333
[TBL] [Abstract][Full Text] [Related]
6. C/EBPβ: A transcription factor associated with the irreversible progression of Alzheimer's disease.
Yao Q; Long C; Yi P; Zhang G; Wan W; Rao X; Ying J; Liang W; Hua F
CNS Neurosci Ther; 2024 Apr; 30(4):e14721. PubMed ID: 38644578
[TBL] [Abstract][Full Text] [Related]
7. Delta-secretase triggers Alzheimer's disease pathologies in wild-type hAPP/hMAPT double transgenic mice.
Wu Z; Liu X; Cheng L; Ye K
Cell Death Dis; 2020 Dec; 11(12):1058. PubMed ID: 33311478
[TBL] [Abstract][Full Text] [Related]
8. BDNF-producing, amyloid β-specific CD4 T cells as targeted drug-delivery vehicles in Alzheimer's disease.
Eremenko E; Mittal K; Berner O; Kamenetsky N; Nemirovsky A; Elyahu Y; Monsonego A
EBioMedicine; 2019 May; 43():424-434. PubMed ID: 31085101
[TBL] [Abstract][Full Text] [Related]
9. TNF receptor 2 knockout mouse had reduced lung cancer growth and schizophrenia-like behavior through a decrease in TrkB-dependent BDNF level.
Yeo IJ; Yu JE; Kim SH; Kim DH; Jo M; Son DJ; Yun J; Han SB; Hong JT
Arch Pharm Res; 2024 Apr; 47(4):341-359. PubMed ID: 38592583
[TBL] [Abstract][Full Text] [Related]
10. Total flavonoids of Cynomorium songaricum attenuates cognitive defects in an Aβ 1-42 -induced Alzheimer's disease rat model by activating BDNF/TrkB signaling transduction.
Gu Z; Lv X; Guo Y; Qi M; Ge B
Neuroreport; 2023 Dec; 34(17):825-833. PubMed ID: 37851367
[TBL] [Abstract][Full Text] [Related]
11. Atypical PKC, PKCλ/ι, activates β-secretase and increases Aβ
Sajan MP; Hansen BC; Higgs MG; Kahn CR; Braun U; Leitges M; Park CR; Diamond DM; Farese RV
Neurobiol Aging; 2018 Jan; 61():225-237. PubMed ID: 29032894
[TBL] [Abstract][Full Text] [Related]
12. Zein-Based Nanoparticles Improve the Therapeutic Efficacy of a TrkB Agonist toward Alzheimer's Disease.
Wang G; Han J; Meng X; Kang SS; Liu X; Sun YE; Luo Q; Ye K
ACS Chem Neurosci; 2023 Sep; 14(17):3249-3264. PubMed ID: 37583253
[TBL] [Abstract][Full Text] [Related]
13. δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities.
Zhang Z; Tian Y; Ye K
Transl Neurodegener; 2020; 9():1. PubMed ID: 31911834
[TBL] [Abstract][Full Text] [Related]
14. cAMP-mediated secretion of brain-derived neurotrophic factor in developing airway smooth muscle.
Thompson MA; Britt RD; Kuipers I; Stewart A; Thu J; Pandya HC; MacFarlane P; Pabelick CM; Martin RJ; Prakash YS
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2506-14. PubMed ID: 26112987
[TBL] [Abstract][Full Text] [Related]
15. Gut dysbiosis contributes to amyloid pathology, associated with C/EBPβ/AEP signaling activation in Alzheimer's disease mouse model.
Chen C; Ahn EH; Kang SS; Liu X; Alam A; Ye K
Sci Adv; 2020 Jul; 6(31):eaba0466. PubMed ID: 32832679
[TBL] [Abstract][Full Text] [Related]
16. Agomirs upregulating carboxypeptidase E expression rescue hippocampal neurogenesis and memory deficits in Alzheimer's disease.
Jiang D; Liu H; Li T; Zhao S; Yang K; Yao F; Zhou B; Feng H; Wang S; Shen J; Tang J; Zhang YX; Wang Y; Guo C; Tang TS
Transl Neurodegener; 2024 Apr; 13(1):24. PubMed ID: 38671492
[TBL] [Abstract][Full Text] [Related]
17. Differential Regulation of Neurotrophic Factors During Pathogenic Tau-Aggregation in a Tau Transgenic Mouse Model for Alzheimer's Disease: A Protocol for Double-Labeling mRNA by In Situ Hybridization and Protein Epitopes by Immunohistochemistry.
Schindowski K
Methods Mol Biol; 2024; 2754():361-385. PubMed ID: 38512677
[TBL] [Abstract][Full Text] [Related]
18. γ-Secretase inhibitor alleviates lipopolysaccharide-induced myocardial injury through regulating JAK2/STAT3 signaling.
Fang J; Guan H
Environ Toxicol; 2024 Jan; 39(1):135-147. PubMed ID: 37671635
[TBL] [Abstract][Full Text] [Related]
19. Cognitive impairment is associated with BDNF-TrkB signaling mediating synaptic damage and reduction of amino acid neurotransmitters in heart failure.
Wang L; Lu Z; Teng Y; Pan W; Li Y; Su S; Chang J; Zhao M
FASEB J; 2024 Jan; 38(1):e23351. PubMed ID: 38085181
[TBL] [Abstract][Full Text] [Related]
20. Reduced mastication during growth inhibits cognitive function by affecting trigeminal ganglia and modulating Wnt signaling pathway and ARHGAP33 molecular transmission.
Misawa-Omori E; Okihara H; Ogawa T; Abe Y; Kato C; Ishidori H; Fujita A; Kokai S; Ono T
Neuropeptides; 2023 Dec; 102():102370. PubMed ID: 37634443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
